Abstract
ObjectivesPrior studies suggest use of genetic testing (GT) varies by race. In gynecologic cancer patients, we assessed frequency of positive tumor next generation sequencing (NGS) results that met ESMO 2019...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Paper Title
Journal
Date
